Leanne Hobbs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A cloud-based repository that creates a digital fingerprint of engineered microorganisms has been successfully trialed.

South Australia accelerates COVID-19 vaccine development The UniSA-Sementis vaccine aims to target mutant variants. Credit: Chalffy / Getty Images. A South Australian immunologist has been awarded $3 million from the Federal Government to accelerate the development of a next-generation COVID-19 vaccine, which may become a second line of defence against the virus. The grant is for a vaccine based on the Sementis Copenhagen Vector (SCV) platform, which will target mutant strains. It can either be received as a stand-alone vaccine or as a booster to complement current vaccines . John Hayball, re...

Credit: University of South Australia A leading South Australian immunologist has been awarded $3 million from the Federal Government to accelerate work on a locally developed Covid-19 vaccine, in what's anticipated to be the second line of defence against the virus. Professor John Hayball is a researcher at the University of South Australia and Chief Scientific Officer at Adelaide biotechnology company Sementis. UniSA and Sementis have partnered in the development of a next-generation Covid-19 vaccine based on the Sementis Copenhagen Vector (SCV) platform. The vaccine has been in development...

South Australian immunologist receives $3 million to accelerate work on Covid-19 vaccine A leading South Australian immunologist has been awarded $3 million from the Federal Government to accelerate work on a locally developed Covid-19 vaccine, in what's anticipated to be the second line of defence against the virus. Professor John Hayball is a researcher at the University of South Australia and Chief Scientific Officer at Adelaide biotechnology company Sementis. UniSA and Sementis have partnered in the development of a next-generation Covid-19 vaccine based on the Sementis Copenhagen Vector ...